Clinical trial
Prospective Comparison of the Tuberculin Skin Test and Interferon-Gamma Release Assays in Diagnosing Infection With Mycobacterium Tuberculosis and in Predicting Progression to Tuberculosis
NCT01622140 is registered in ClinicalTrials.gov with Centers for Disease Control and Prevention as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Prospective Comparison of the Tuberculin Skin Test and Interferon-Gamma Release Assays in Diagnosing Infection With Mycobacterium Tuberculosis and in Predicting Progression to Tuberculosis
- Lead sponsor
- Centers for Disease Control and Prevention
- Phase
- Observational
- Overall status
- Completed
- Start date
- October 31, 2012
- Completion date
- December 31, 2020
- Enrollment
- 21,334 (actual)
- Sites
- 10
Conditions
As the registry lists them; a condition with its own page is linked.
latent tuberculosis infection, tuberculosis